What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

PrECOG Cancer Research Group

Home
United States
Philadelphia, PA
PrECOG Cancer Research Group

Innovative cancer research studies developed through industry partnerships and networks.

Supporting ECOG-ACRIN Cancer Research Group's efforts to advance cancer care

06/01/2026

How well does osimertinib—with or without chemotherapy—work to control EGFR-positive in patients not participating in a clinical trial? The PrE1702 research study aims to find out. Learn more: https://bit.ly/pre1702-study

05/29/2026

Dr. Taofeek Owonikoko of is leading PrE0510, a phase 2 clinical trial treating patients with extensive-stage small cell lung cancer ( ) who have not yet had systemic therapy. Learn more: https://bit.ly/PrE0510

05/25/2026

The PrE1702 research study is evaluating how well osimertinib with or without chemotherapy works to control EGFR-positive in patients not participating in a clinical trial. Learn more: https://bit.ly/pre1702-study

05/22/2026

The PrE0510 clinical trial, led by Dr. Taofeek Owonikoko of , aims to determine the optimal dose of ivonescimab in combo with carboplatin & etoposide for patients with small cell lung cancer. More: https://bit.ly/PrE0510

Address

1818 Market Street, Suite 3000
Philadelphia, PA
19118

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+12157897001

Website

http://www.precogllc.org/

Alerts

Be the first to know and let us send you an email when PrECOG Cancer Research Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.